ISSN: 2168-9857
Simon Allen
Introduction: Type-III chronic prostatitis (CP) is characterized by pelvic pain, sexual dysfunction and urinary symptoms in the absence of infection. It is also known as chronic pelvic pain syndrome (CPPS) This study discusses the cause of CP/CPPS, the understanding of which can help to find effective therapy.
Materials: An observational clinical trial, before and 6 months after treatment with Thermobalancing therapy (TT) and Dr Allen’s therapeutic device (DATD), which uses natural body energy, has been used. The treatment group-45 patients with CP/CPPS, who received DATD, and the control group-45 men with CP/CPPS, who not.
Methods: The National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI) include examination of pain score and quality of life (QoL), ultrasound-prostate volume (PVmL), uroflowmetry-maximum urine flow rate (Qmax).
Results: Compared to control, significant improvements from baseline to endpoint were seen: pain score, 10.38 to 3.58 against 10.49 to 9.71, (P